Apimeds Pharmaceuticals US, Inc. APUS
Key Stats
- Today's Range
- $5.39 – $9.14
- 50-Day Range
- $1.51 – $9.14
- 52-Week Range
- $1.51 – $59.70
- Volume
- 37.11 million shs
- Average Volume
- 4.35 million shs
- Market Cap
- $7.42 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.69%
- Days to Cover
- 1.00
About Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evaluated for the treatment of pain and inflammation associated with knee osteoarthritis. The Company operates in two segments: the biopharmaceutical segment, which is focused on the clinical development of Apitox through Lokahi, and the digital asset operations segment, which encompasses the holding, sale, and advancement of the MindWaveDAO blockchain and related digital assets through MindWave.
Related Stocks
Compare head-to-head: APUS vs LLY·APUS vs JNJ·APUS vs ABBV·APUS vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.